BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Acquires 242,509.47 in Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 15,281 shares of the business’s stock in a transaction dated Monday, October 14th. The shares were bought at an average cost of 15.87 per share, with a total value of 242,509.47. Following the transaction, the insider now directly owns 20,686,197 shares of the company’s stock, valued at 328,289,946.39. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Wednesday, October 16th, Saba Capital Management, L.P. purchased 29,795 shares of BlackRock Health Sciences Term Trust stock. The shares were purchased at an average price of 15.81 per share, for a total transaction of 471,058.95.
• On Monday, September 30th, Saba Capital Management, L.P. acquired 8,012 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.84 per share, with a total value of 126,910.08.
• On Friday, September 27th, Saba Capital Management, L.P. acquired 1,633 shares of BlackRock Health Sciences Term Trust stock. The shares were purchased at an average price of 15.89 per share, for a total transaction of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. bought 300 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average cost of 15.73 per share, with a total value of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. purchased 2,006 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.98 per share, for a total transaction of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. acquired 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 16.14 per share, with a total value of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. bought 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BMEZ opened at 15.67 on Friday. The company has a 50-day moving average price of 15.87 and a two-hundred day moving average price of 15.50. BlackRock Health Sciences Term Trust has a 12 month low of 12.93 and a 12 month high of 16.59.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be issued a $0.176 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.48%.

Institutional Trading of BlackRock Health Sciences Term Trust

Several institutional investors have recently bought and sold shares of the stock. Dakota Wealth Management raised its stake in BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after acquiring an additional 915 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its position in shares of BlackRock Health Sciences Term Trust by 21.7% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock worth $96,000 after purchasing an additional 1,038 shares in the last quarter. Kingswood Wealth Advisors LLC lifted its holdings in BlackRock Health Sciences Term Trust by 9.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock valued at $360,000 after purchasing an additional 1,845 shares during the last quarter. Comerica Bank lifted its holdings in BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after purchasing an additional 3,671 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its position in BlackRock Health Sciences Term Trust by 17.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company’s stock valued at $448,000 after buying an additional 4,604 shares in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.